We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
X-Ray Crystallography: Assessment and Validation of Protein Small Molecule Complexes for Drug Discovery
News

X-Ray Crystallography: Assessment and Validation of Protein Small Molecule Complexes for Drug Discovery

X-Ray Crystallography: Assessment and Validation of Protein Small Molecule Complexes for Drug Discovery
News

X-Ray Crystallography: Assessment and Validation of Protein Small Molecule Complexes for Drug Discovery

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "X-Ray Crystallography: Assessment and Validation of Protein Small Molecule Complexes for Drug Discovery"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Introduction
Crystallography is the key initial component for structure-based and fragment based drug design and can often generate leads that can be developed into high potency drugs. Therefore, huge sums of money are committed based on the outcome of crystallography experiments and their interpretation.

Areas covered
Various types of inaccuracies found within the PDB are identified and the ramifications of these errors are discussed. The reader will gain an understanding of the key parameters that need to be inspected before a structure can be used in drug discovery efforts, as well as an appreciation of the difficulties of correctly interpreting electron density for small molecules. The reader will also be introduced to methods for validating small molecules within the context of a macromolecular structure.

Expert opinion
One of the reasons that ligand identification and positioning, within a macromolecular crystal structure, is so difficult is that the quality of small molecules widely varies.

The article is published online in Expert Opinion in Drug Discovery and is free to access.

Advertisement